| Active ingredient (INN) | Acarbose |
|---|
| Brand names | Viatris, Glucobay |
|---|
| ATC level 5 | A10BF01 |
|---|
| ATC level 4 | A10BF |
|---|
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | Generics (UK) Limited, MORNINGSIDE HEALTHCARE LIMITED, HIKMA PHARMACEUTICALS USA INC. |
|---|
| Registrations on file | 17 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| ACARBOSE 50MG TABLETS | 50MG | tablet | 🇬🇧 GB | Generics (UK) Limited | Active |
| ACARBOSE 100MG TABLETS | 100MG | tablet | 🇬🇧 GB | Generics (UK) Limited | Active |
| ACARBOSE 50 MG TABLETS | 50 MG | tablet | 🇬🇧 GB | MORNINGSIDE HEALTHCARE LIMITED | Active |
| ACARBOSE 100 MG TABLETS | 100 MG | tablet | 🇬🇧 GB | MORNINGSIDE HEALTHCARE LIMITED | Active |
| Acarbose | 25mg/1 | tablet | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Acarbose | 50mg/1 | tablet | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Acarbose | 100mg/1 | tablet | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| Wgr | 50 mg | — | 🇦🇺 AU | — | Active |
| Gppl | 50 mg | — | 🇦🇺 AU | — | Active |
| Gppl | 100 mg | — | 🇦🇺 AU | — | Active |
| GLARBOSE acarbose | 50 mg | — | 🇦🇺 AU | — | Active |
| GLYBOSAY acarbose | 100 mg | — | 🇦🇺 AU | — | Active |
| Viatris | 100 mg | — | 🇦🇺 AU | — | Active |
| GLYBOSAY acarbose | 50 mg | — | 🇦🇺 AU | — | Active |
| Wgr | 100 mg | — | 🇦🇺 AU | — | Active |